Status: Recruiting
Pilot Imaging Study of Leukemia
This is a prospective pilot study, the primary aim of which is to determine whether the presence of 18F FLT imaging signal uptake abnormalities correlate with clinically validated evidence of hematopoietic malignant disease (e.g. MRD, molecular, flow or histology) after immunotherapy and other treatments.
Participants needed: 60
Trial details
Phase: Phase 1Age: 4-80Biological sex: AllType: InterventionalSponsor: University of OklahomaUpdated: Apr 23, 2026Locations: 3
Eligibility criteria
Aged 4 to 80 years [+9]
Patients with uncontrolled infections [+2]